Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes—exploratory analysis of the Clalit registry

Data on using the 21-gene Recurrence Score (RS) testing on second breast cancer (BC; second primary or local recurrence) are lacking. This cohort study examined patients with first and second BC, who underwent 21-gene testing both times. It included a ‘study-cohort’ (60 N0/N1mi/N1 ER + HER2‒ BC pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Shachar, Shlomit S., Leviov, Michelle, Yerushalmi, Rinat, Drumea, Karen, Tokar, Margarita, Soussan-Gutman, Lior, Bareket-Samish, Avital, Sonnenblick, Amir, Ben-Baruch, Noa, Evron, Ella, Gal-Yam, Einav Nili, Paluch-Shimon, Shani, Bar-Sela, Gil, Goldvaser, Hadar, Stemmer, Salomon M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541873/
https://www.ncbi.nlm.nih.gov/pubmed/37775723
http://dx.doi.org/10.1038/s41523-023-00586-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541873/
https://www.ncbi.nlm.nih.gov/pubmed/37775723
http://dx.doi.org/10.1038/s41523-023-00586-3

Ejemplares similares